Loading clinical trials...
Loading clinical trials...
A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of TurbAlign™ to Achieve Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery (FESS) (GAIA)
Conditions
Interventions
Implantation of Spirair device into the middle turbinates
TurbAlign
Locations
5
United States
Northwest Community Hospital
Arlington Heights, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Tandem Clinical Research
Marrero, Louisiana, United States
LSU Health Science Center
Shreveport, Louisiana, United States
Houston Methodist ENT Specialists
Houston, Texas, United States
Start Date
August 5, 2025
Primary Completion Date
April 1, 2026
Completion Date
June 1, 2026
Last Updated
June 18, 2025
NCT06687629
NCT06812676
NCT00503802
Lead Sponsor
Spirair, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions